| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a11f8f9e254c764a032a4786c4070b17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9053336f864c5a26dbb215cf18470db1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a450d240dc9d720d48b0ec638436ae33 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-44 |
| filingDate |
2009-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61f03992dbe61026c20faeb5a88eaf08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_936b79840d9fc2e6230b18ba14f34389
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a67fccc070d52c5746992fcdcc64d2b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_accd3768facba7381f8e5b0700790d30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d124bdf295b6c2313a6a6a8e18e9c17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37749b9f705a1dba1ef86af4c5aace3c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a10f182ca09d0494f5f1a42900bb35cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db6725a4841ade530e581ef1640b1112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5409db06aab2cacd2211420d298d6faf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a4b1fd6f72d6e0f483395f4dc69d57d |
| publicationDate |
2011-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-PI0903089-A2 |
| titleOfInvention |
recombinant peptides and leishmania antigens mimetic protein motifs and their applications |
| abstract |
RECOMBINANT PEPTIDES AND MIMETIC PROTEIN REASONS TO LEISHMANIA ANTIGENS AND THEIR APPLICATIONS. The present invention relates to the selection, characterization and use of recombinant peptides, their reverse sequences and protein motifs that mimic partial antigenic regions of Leishmanian proteins and antigens of diagnostic and vaccine interest for diseases caused by Leishmania parasites. The peptides object of this invention were selected by "Phage Display" and are targets for use in immunodiagnostics and in vaccine compositions to control the different types of disease caused by parasites of the aforementioned genus because they are specifically immunoreactive with the serum of infected individuals. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018051291-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018037343-A1 |
| priorityDate |
2009-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |